Technology news and Jobs 
VIRTUALISATION Dysport approved by FDA for wrinkle treatment
VIRTUALISATION Dysport approved by FDA for wrinkle treatment | Dysport approved by FDA for wrinkle treatment |
|
| by William Atkins | |
| Monday, 04 May 2009 | |
|
Page 1 of 2   
Featured Whitepaper
5 Best Practices for Smartphone Support
Dysport, previously called Reloxin, is made from the type A toxin called Clostridium botulinim. It works by relaxing the muscles that are causing the wrinkles and worry lines, what are also called glabellar lines. According to the website of the drug’s maker Ipsen Biopharm, Dysport is scientifically called abobotulinumtoxinA. This new wrinkle drug is made from the same active ingredient (C. botulinim) as Botox, made by Allergan, which has been in the news lately, too. In the iTWire article FDA to strengthen warnings on Botox type drugs, the FDA is requiring stronger warning labels on all drugs made with C. botulinim because of the possibilities of breathing and swallowing problems, along with rare reported cases of hospitalization and death. When C. botulinim is injected into a wrinkle the toxin interferes with (the release of acetylcholine within the neuromuscular junction of) nerve impulses within the muscles, and, thus, causes paralysis of those local muscles. The muscles are then unable to contract for several months. Page two concludes. |
| < Next story in category | Previous story in the category > |
|---|
